Our advisors have supported early phase drug and new medical device concerns, as well as established healthcare companies with stable and growing earnings streams.  We have deep influencer and Street  relationships across the space, and enjoy the industry’s complexity as it requires a strategic partner like Alpha to create a truly “best practices” approach.